All Insights and Resources

Characterisation

Ensuring a Robust Supply of Biomaterials to Meet a Growing Industry

30 December 2021

Ensuring a Robust Supply of Biomaterials to Meet a Growing Industry

Interview - Q&A

Risk-Based Assay Development Strategies for Cell Therapies

24 June 2021

Risk-Based Assay Development Strategies for Cell Therapies

Getting a cell or cell-based

Reproducibility, Reliability, Robustness: Establishing Cornerstones for Standardisation Of Cell Manufacturing

<img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/empty_140_140.png" alt="Reproducibility, Reliability, Robustness: Establishing Cornerstones for Standardisation Of Cell Manufacturing" />

27 May 2020

Reproducibility, Reliability, Robustness: Establishing Cornerstones for Standardisation Of Cell Manufacturing

Reproducibility, Reliability, Robustness: Establishing Cornerstones for Standardisation Of Cell Manufacturing

<img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/empty_140_140.png" alt="Reproducibility, Reliability, Robustness: Establishing Cornerstones for Standardisation Of Cell Manufacturing" />

27 May 2020

Reproducibility, Reliability, Robustness: Establishing Cornerstones for Standardisation Of Cell Manufacturing

Which manufacturing parameters have significant

POPULAR NEWS ITEMS

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

26 May 2022

Castle Creek Bioscience Achieves $112.8 Million Financing to Advance Gene Therapies

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

25 May 2022

Key Takeaways from ASGCT 2022

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

24 May 2022

Umoja and Lupagen Collaboration Drives Improved Delivery for Next Generation in vivo CAR-T

What’s Next for Commercial Cell Therapy Manufacturing?

15 March 2019

What’s Next for Commercial Cell Therapy Manufacturing?

Video - On Demand Library

RECOMENDED TOPICS

Automation & Digitisation

Characterisation

Skills, Talent & Development

POPULAR NEWS ITEMS

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

Castle Creek Bioscience Achieves $112.8 Million Financing to Advance Gene Therapies

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

Key Takeaways from ASGCT 2022

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

Umoja and Lupagen Collaboration Drives Improved Delivery for Next Generation in vivo CAR-T

logo_mobile_footer

Company

Resources

Network

Clarion Events Limited is registered in England and Wales, Company Number 00454826, VAT No. GB 843845601 Registered Office: Bedford House, 69-79 Fulham High Street, London, SW6 3JW, United Kingdom.

Phacilitate is a part of Clarion Events Limited. © Phacilitate 2022